The way sponsors design enrollment is shifting, and embedded research in clinical trials sits at the center of that change. Rather than asking patients to travel to dedicated research facilities, this approach folds studies into the everyday practices where people already see their doctors. For pharmaceutical sponsors and CRO clinical operations leaders, knowing how embedded research in clinical trials works, and how it diverges from conventional site networks, is fast becoming part of sound trial planning.
What Does Embedded Research in Clinical Trials Actually Mean?
Embedded research in clinical trials describes studies that live inside established community medical practices instead of running out of separate research centers. The physician and care team who already treat the patient take part in the study alongside their normal duties. That means a patient can enroll in a trial right where they receive routine care, removing the disruption and unfamiliarity that often discourage participation in the first place.
Can This Model Speed Up Clinical Trial Enrollment?
Yes, and the reason is straightforward. The candidate pool already exists inside the practice, so eligible patients surface during ordinary appointments rather than through expensive outreach campaigns. The confidence patients place in a familiar physician carries into the consent conversation, which raises both sign up and completion rates. Sponsors see clinical trial enrollment accelerate while dropout falls, easing two of the biggest pressures on study budgets and timelines.
Where Does the Real World Data Advantage Come From?
Studies run within routine care capture how therapies behave in genuine clinical conditions rather than inside controlled research bubbles. The participants tend to be more varied and more representative of the wider population, which makes the resulting real world data far more useful to regulators and payers weighing real life effectiveness. For many sponsors, this closeness to actual practice is the quiet reason embedded research in clinical trials yields evidence they can stand behind.
How Does It Compare With Standalone Site Networks?
Standalone site networks treat research as a freestanding operation, pulling patients in from elsewhere and frequently keeping care and study activity separate. The embedded approach does the opposite, situating the trial inside the practice so treatment and research move in step. Scale is a genuine strength of standalone networks, yet they often forfeit the trusted doctor patient bond that powers community based enrollment. Embedded research partners protect that bond, and that protection is precisely what sets the model apart.
What Separates a Strong Embedded Research Partner From the Rest?
When weighing embedded research partners, sponsors should examine how deep the community practice network runs, how diverse the patient populations are, and how smoothly the study folds into existing routine care research routines. The best partners can launch trials across many community locations without sacrificing the local trust that drives recruitment. FOMAT operates the largest embedded research organization in the United States, with 35 plus investigator sites across six states, opening direct access to community patient populations that standalone networks rarely reach.
Is Integrating Clinical Trials Into Routine Care the Right Call?
For the majority of sponsors, integrating clinical trials into routine care offers a better mix of speed, diversity, and data integrity than legacy models can. Timelines compress, retention climbs, and the evidence produced mirrors real world treatment more faithfully. With regulators putting growing emphasis on representative participation, embedded research in clinical trials is shifting from an edge a few sponsors enjoy to a baseline most will expect. According to the FDA, broad and representative participation strengthens the quality and applicability of trial results.
Partner With FOMAT for Embedded Research in Clinical Trials
FOMAT helps sponsors and CROs run studies inside trusted community care settings through the largest embedded research network in the country. To see how embedded research in clinical trials can move your next study faster, visit our investigator network or review our approach to diversity in clinical trials.